CXCL4: A new biomarker of diagnosis and severity in systemic sclerosis?

被引：0
|
作者：
Marie, I. [1 ]
机构：
[1] CHU Rouen, Dept Med Interne, F-76031 Rouen, France
来源：
REVUE DE MEDECINE INTERNE | 2015年 / 36卷 / 02期
关键词：
Systemic sclerosis; Dendritic cells; CXCL4; Pathophysiology; Diagnosis; Prognosis; Therapy; PROTEOME-WIDE ANALYSIS; GROWTH-FACTOR-BETA; PLATELET FACTOR-IV; OCCUPATIONAL-EXPOSURE; CHEMOKINE PRODUCTION; DENDRITIC CELLS; PLATELET-FACTOR-4; SCLERODERMA; ACTIVATION; DISEASE;
D O I：
10.1016/j.revmed.2014.10.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：69 / 72
页数：4
相关论文
共 50 条
  • [21] CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis
    van der Kroef, Maarten
    Carvalheiro, Tiago
    Rossato, Marzia
    de Wit, Floor
    Cossu, Marta
    Chouri, Eleni
    Wichers, Catharina G. K.
    Bekker, Cornelis P. J.
    Beretta, Lorenzo
    Vazirpanah, Nadia
    Trombetta, Elena
    Radstake, Timothy R. D. J.
    Angiolilli, Chiara
    JOURNAL OF AUTOIMMUNITY, 2020, 111
  • [22] A New Role for CXCL4 in Respiratory Syncytial Virus Disease
    Wiseman, Dexter J.
    Thwaites, Ryan S.
    Openshaw, Peter J. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (05) : 648 - 649
  • [23] The use of circulating SAA and CXCL4 to predict outcome of osteosarcoma at diagnosis
    Flores, Ricardo J.
    CANCER RESEARCH, 2016, 76
  • [24] CXCL4, a chemokine upregulated in systemic sclerosis patients, abrogates TLR9 signaling and central tolerance in B cells
    Kioon, Marie Dominique Ah
    Cakan, Elif
    Garcia-Carmona, Yolanda
    Cunningham-Rundles, Charlotte
    Meffre, Eric
    Barrat, Franck J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [25] CXCL4 MAY PLAY A KEY ROLE IN SYSTEMIC SCLEROSIS BY DRIVING CD4 T CELLS TO PRODUCE IL-17
    Affandi, A. J.
    Cardoso, S. C. Silva
    Garcia-Perez, S.
    Marut, W.
    van Roon, J. A. G.
    Radstake, T. R. D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1104 - 1104
  • [26] Extracellular vesicles-derived CXCL4 is a candidate serum tumor biomarker for colorectal cancer
    Xie, Jinye
    Xing, Shan
    Jiang, Hongbo
    Zhang, Jiaju
    Li, Daxiao
    Niu, Shiqiong
    Huang, Zhijian
    Yin, Haofan
    ISCIENCE, 2024, 27 (04)
  • [27] CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
    Roberto Lande
    Ernest Y. Lee
    Raffaella Palazzo
    Barbara Marinari
    Immacolata Pietraforte
    Giancarlo Santiago Santos
    Yves Mattenberger
    Francesca Spadaro
    Katia Stefanantoni
    Nicoletta Iannace
    Aleksandra Maria Dufour
    Mario Falchi
    Manuela Bianco
    Elisabetta Botti
    Luca Bianchi
    Montserrat Alvarez
    Valeria Riccieri
    Marie-Elise Truchetet
    Gerard C.L. Wong
    Carlo Chizzolini
    Loredana Frasca
    Nature Communications, 10
  • [28] CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
    Lande, Roberto
    Lee, Ernest Y.
    Palazzo, Raffaella
    Marinari, Barbara
    Pietraforte, Immacolata
    Santos, Giancarlo Santiago
    Mattenberger, Yves
    Spadaro, Francesca
    Stefanantoni, Katia
    Iannace, Nicoletta
    Dufour, Aleksandra Maria
    Falchi, Mario
    Bianco, Manuela
    Botti, Elisabetta
    Bianchi, Luca
    Alvarez, Montserrat
    Riccieri, Valeria
    Truchetet, Marie-Elise
    Wong, Gerard C. L.
    Chizzolini, Carlo
    Frasca, Loredana
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [29] Macrophage phenotype modulation by CXCL4 in atherosclerosis
    Gleissner, Christian A.
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [30] A new obligate CXCL4–CXCL12 heterodimer for studying chemokine heterodimer activities and mechanisms
    Khanh T.P. Nguyen
    Brian Volkman
    Didier Dréau
    Irina V. Nesmelova
    Scientific Reports, 12
12345